Megakaryocyte gene targeting mediated by restricted expression of recombinase Cre

Summary

The availability of mice with tissue-specific expression of recombinase Cre is the limiting step for a successful gene targeting by the Cre-LoxP methodology. This work aimed at generating transgenic mice with restricted expression of recombinase Cre in megakaryocytes and platelets, driven by the promoter of the αIIb gene (mαIIb-cre). Mice oocytes were microinjected with a 4.1 Kb construct comprising a 2.7 Kb promoter fragment of the glycoprotein αIIb gene, linked to the CrecDNA and followed by the polyA tail of the SV40. We found four mice with positive DNA genotype and three probable sites of genomic integration of the transgene. Only two of the founders showed presence of Cre-mRNA and production of Cre protein, restricted to megakaryocytes. The activity of Cre in mediating gene targeting was assessed by crossing mαIIb-cre mice to Cre-reporter mice (ROSA26-lacZ). The activity of β-galactosidase, detected only in megakaryocytes, was sufficient to generate intense staining of X-Gal in hepatic haematopoietic islands of 14.5 dpc fetuses, in bone marrow megakaryocytes and platelets from adult mice as well as in vitro cultured megakaryocytes differentiated from bone marrow hematopoietic stem cells. Moreover, the recombinase activity was sufficient to produce the specific gene targeting of a floxed CD40L allele in megakaryocytes. The mαIIb-cre transgenic mice with restricted production of Cre in megakaryocytes, offers a selective, alternative, new tool for the genetic analysis of platelet pathophysiology.

Keywords

Tissue-specific transgenesis - Cre in megakaryocytes - Cre-loxP - gene targeting mediated by Cre

• References

• 1 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720-722.
• 2 Handagama P. et al. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alphaIIb-beta3 glycoprotein IIb-IIIa). Blood 1993; 82: 135-138.
• 3 Phillips DR. et al. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-843.
• 4 Savage B. et al. Initiation of platelet adhesion by arrest onto fibrinogen or trans-location on von Willebrand factor. Cell 1996; 84: 289-297.
• 5 Moroi M, Jung SM. Integrin-mediated platelet adhesion. Front Biosci 1998; 03: D719-D728.
• 6 Shattil S. et al. Integrin signaling: the platelet paradigm. Blood 1998; 91: 2645-2657.
• 7 Larrucea S. et al. Agonist-induced aggregation of CHO cells coexpressing human receptors for fibrinogen integrin αIIbβ3) and the platelet activating factor: Dissociation between adhesion and aggregation. Blood 2002; 99: 2819-2827.
• 8 Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109: 5087-5095.
• 9 Nagy A. et al. Derivation of completely cell culture-derived mice from early passage embryonic stem cells. Proc Natl Acad Sci USA 1993; 90: 8424-8428.
• 10 Nagy A. et al. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press.; Third Edition 2003
• 11 Montoliu L. Generation of transgenic mice. Günther Schütz´s Laboratory Div Mol Bio Cell. German Cancer Research Center Heidelberg 1997
• 12 Gu H. et al. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73: 1155-1164.
• 13 Kupriyanov S, Baribault H. Genetic control of extraembryonic cell lineages studied with tetraploid<-->diploid chimeric concepti. Biochem. Cell Biol 1998; 76: 1017-1027.
• 14 Zambrowicz BP. et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 1997; 94: 3789-3794.
• 15 Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
• 16 Laird PW. et al. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.
• 17 Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory Press; Cold Spring Harbour, New York: 2001
• 18 Jiang M. et al. Mouse gene knockout and knockin strategies and methods as applied to the alpha subunits of the Gi/Go family of G proteins. Methods in Enzymolgy 2002; 344: 277-298.
• 19 Kisanuki YY. et al. Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in Vivo . Develop Biol 2001; 230: 230-242.
• 20 Thompson A. et al. Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. J Biol Chem 1996; 271: 22976-22982.
• 21 Ravid K. et al. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci USA 1991; 88: 1521-1525.
• 22 Nguyen HG. et al. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood 2005; 106: 1559-1564.
• 23 Tiedt R. et al. Pf4-Cre transgenic mice allow generating lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo . Blood 2007; 109: 1503-1506.
• 24 Ravanat C. et al. Gene cloning of rat and mouse platelet glycoprotein V: Identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 1997; 89: 3253-3262.
• 25 Tropel P. et al. A 2.7-kb portion of the 5’ flanking region of the murine glycoprotein αIIb gene is transcriptionally active in primitive hematopoietic progenitor cells. Blood 1997; 90: 2995-3004.
• 26 Tronik-LeRoux D. et al. Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter. J Exp Med 1995; 181: 2141-2151.
• 27 Poujol C. et al. Ultrastructural analysis of bone marrow hematopoyesis in mice transgenic for the thymidine kinase driven by the αIIb promoter. Blood 1998; 92: 2012-2023.
• 28 Ziegler S. et al. A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and sites of embryonic hematopoiesis in transgenic mice. Blood 2002; 100: 1072-1074.
• 29 Yang G. et al. Experimental study on intramuscular injection of eukaryotic expression vector pcDNA3-IL-6 on BXSB mice. Chin Med J Engl. 1998; 111: 38-42.
• 30 Zhou W. et al. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 1997; 89: 1551-1559.
• 31 Emambokus NR, Frampton J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. Immunity 2003; 19: 33-45.
• 32 Chen YQ. et al. Ectopic expression of platelet integrin αIIbβ3 in tumor cells from various species and histological origin. Int J Cancer 1997; 72: 642-648.
• 33 Uzan G. et al. Tissue-specific Expression of the Platelet GPIIb Gene. J Biol Chem 1991; 266: 8932-8939.
• 34 Ryding ADS. et al. Conditional Transgenic Technologies. J Endocr 2001; 171: 1-14.
• 35 Thyagarajan B. et al. Mammalian genomes contain active recombinase recognition sites. Gene 2000; 244: 47-54.
• 36 Kolb AF, Siddell SG. Genomic targeting with an MBP-Cre fusion protein. Gene 1996; 183: 53–60. Erratum in: Gene 1997; 189: 149.
• 37 Mikkola HK. et al. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 2003; 101: 508-516.